Table 3 Results of antiseptic solution testing for antifungal activity, presented in log reduction values.

From: Quality of life and therapeutic regimen management in onychomycosis patients and in vitro study of antiseptic solutions

 

PVP-I

PHMB-B

OCT-D

SOS

Aspergillus niger

3.10 ± 0.10 (n = 3)

3.10 ± 0.10 (n = 3)

3.10 ± 0.10 (n = 3)

3.10 ± 0.10 (n = 3)

Candida albicans

4.39 ± 0.12 (n = 2)

4.39 ± 0.12 (n = 2)

4.39 ± 0.12 (n = 2)

3.44 ± 0.75 (n = 3)

Candida parapsilosis

4.50 ± 0.49 (n = 4)

4.63 ± 0.08 (n = 2)

4.63 ± 0.08 (n = 2)

3.54 ± 0.56 (n = 5)a

4.35 ± 0.72 (n = 3)b

Trichophyton interdigitale

4.29 ± 0.39 (n = 2)

4.40 ± 0.34 (n = 3)

4.29 ± 0.39 (n = 2)

3.62 ± 0.68 (n = 4)

Trichophyton rubrum

4.18 ± 0.01 (n = 2)

3.70 ± 0.53 (n = 6)

4.18 ± 0.36 (n = 4)

3.23 ± 0.23 (n = 8)

  1. Values of log10 reduction mean and standard deviation. In parentheses; n number of valid tests. PVP-I povidone-iodine, PHMB-B polyhexamethylene biguanide-betaine, OCT-D octenidine dihydrochloride, SOS super-oxidized solution. aTested compound at 80% (according to the protocol); bTested compound at 95%.
Back to article page